- Home
- VIST vs KRYS Comparison
VIST vs KRYS Comparison
Compare VIST & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VIST | KRYS |
|---|---|---|
| Founded | 2017 | 2015 |
| Country | Mexico | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3B | 6.3B |
| IPO Year | 2019 | 2017 |
Fundamental Metrics
Financial Performance| Metric | VIST | KRYS |
|---|---|---|
| Price | $55.90 | $277.55 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 10 |
| Target Price | $72.25 | ★ $250.50 |
| AVG Volume (30 Days) | ★ 792.0K | 299.1K |
| Earning Date | 02-25-2026 | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 30.45 | ★ 275.72 |
| EPS | ★ 6.75 | 6.66 |
| Revenue | ★ $2,226,451,000.00 | $373,164,000.00 |
| Revenue This Year | $42.80 | $36.14 |
| Revenue Next Year | $15.85 | $42.38 |
| P/E Ratio | ★ $7.75 | $41.84 |
| Revenue Growth | 49.86 | ★ 54.51 |
| 52 Week Low | $31.63 | $122.80 |
| 52 Week High | $56.85 | $295.98 |
Technical Indicators
Market Signals| Indicator | VIST | KRYS |
|---|---|---|
| Relative Strength Index (RSI) | 70.65 | 60.99 |
| Support Level | $47.78 | $275.00 |
| Resistance Level | $52.99 | $294.64 |
| Average True Range (ATR) | 1.96 | 11.63 |
| MACD | 0.84 | -0.63 |
| Stochastic Oscillator | 93.37 | 64.97 |
Price Performance
Historical ComparisonAbout VIST Vista Energy S.A.B. de C.V. each representing one series A share with no par value
Vista Energy SAB de CV is an independent oil and gas company. It is focused on shale oil and shale gas exploration at its main assets in Vaca Muerta. The company has operations in Argentina and Mexico. The company operates in a single segment- the exploration and production of Crude oil, Natural gas, and LPG. Geographically, It operates in Argentina and Mexico. it generates the majority of its revenue from Argentina.
About KRYS Krystal Biotech Inc.
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.